- 2024 - 2027 A novel aberrant glycosylated PSA test, a biomarker for evaluating malignant potential to reduce overtreatment of prostate cancer
- 2021 - 2024 Development of PSMA-targeting neutron capture tharapy based theranostics
- 2020 - 2023 バーチャルリアリティを用いたプレハビリテーションプログラムによる術後譫妄予防
- 2020 - 2023 Development of next generation BNCT targeted to the tumor endothelial cell
- 2020 - 2023 分子標的ホウ素中性子捕捉療法の開発
- 2018 - 2021 Development of glycomolecule-based liquid biopsy marker for evaluation of prostate cancer malignancy
- 2017 - 2020 Tumor targeting using boron neutron capture therapy
- 2015 - 2020 Practical application of glycan-targeted biomarker to prevent over-diagnosis and over-treatment of prostate cancer
- 2015 - 2019 Establishment of prostate cancer cell surface glycan targeted-biomarker
- 2015 - 2018 Development of predictive biomarker for kidney transplant disorder by comprehensive structural analysis on serum glycan
- 2012 - 2015 A new glyco-biomarker for comprehensive evaluation of malignant potential in prostate cancer
- 2011 - 2015 Targeted drug delivery to tumor vasculature by annexin A1 binding peptide
- 2011 - 2012 Clinical characteristics of Xp11.2 translocation renal cell carcinoma
Show all